Collegium Pharmaceutical Inc
-
Ticker
COLL
-
Industry
Drugs - Generic More
-
Sector
Healthcare More
- 201-500 Employees
- Based in Canton, Massachusetts
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, focuses on developing and commercializing abuse-deterrent products that incorporate its DETERx platform technology for the treatment of chronic pain and other diseases. Its lead product candidate is Xtampza, an abuse-deterrent, extended-release, oral formulation of oxycodone, a prescribed opioid medication.
REPORT RATINGS
5.0 / 5.0 (2)
Collegium Pharmaceutical Inc reports have an aggregate usefulness score of 5.0 based on 2 reviews.
Collegium Pharmaceutical Inc
Most Recent Responsibility Report
MOST RECENT
2023 ESG Report
Archived Responsibility Reports
Our service enables potential investors to review the most recent and archived Collegium Pharmaceutical Inc Sustainability Report, Collegium Pharmaceutical Inc Corporate Social Responsibility Report, Collegium Pharmaceutical Inc CSR Report, Collegium Pharmaceutical Inc Corporate Responsibility, Collegium Pharmaceutical Inc CR Report, Collegium Pharmaceutical Inc Citizenship Report, Collegium Pharmaceutical Inc ESG Report, and Collegium Pharmaceutical Inc Environmental Report online.